[go: up one dir, main page]

PL1687014T3 - Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi - Google Patents

Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi

Info

Publication number
PL1687014T3
PL1687014T3 PL04818400T PL04818400T PL1687014T3 PL 1687014 T3 PL1687014 T3 PL 1687014T3 PL 04818400 T PL04818400 T PL 04818400T PL 04818400 T PL04818400 T PL 04818400T PL 1687014 T3 PL1687014 T3 PL 1687014T3
Authority
PL
Poland
Prior art keywords
preventing
blood sugar
increased blood
distillers grains
sugar values
Prior art date
Application number
PL04818400T
Other languages
English (en)
Inventor
Karl-Heinz Zirzow
Dirk Bökenkamp
Martin Müller
Dieck Heike Tom
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34585009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1687014(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of PL1687014T3 publication Critical patent/PL1687014T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/20—Malt products
    • A23L7/25—Fermentation of cereal malt or of cereal by malting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
PL04818400T 2003-11-12 2004-11-12 Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi PL1687014T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10352822A DE10352822A1 (de) 2003-11-12 2003-11-12 Verwendung einer zusätzlich fermentierten Getreideschlempe zur Vorbeugung und/oder Behandlung erhöhter Blutzucker-Werte
PCT/EP2004/012875 WO2005046705A1 (de) 2003-11-12 2004-11-12 Verwendung einer zusätzlich fermentierten getreideschlempe zur vorbeugung und/oder behandlung erhöhter blutzucker-werte
EP04818400A EP1687014B1 (de) 2003-11-12 2004-11-12 Verwendung einer zusätzlich fermentierten getreideschlempe zur vorbeugung und/oder behandlung erhähter blutzucker-werte

Publications (1)

Publication Number Publication Date
PL1687014T3 true PL1687014T3 (pl) 2007-09-28

Family

ID=34585009

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04818400T PL1687014T3 (pl) 2003-11-12 2004-11-12 Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi

Country Status (8)

Country Link
US (1) US20070141119A1 (pl)
EP (1) EP1687014B1 (pl)
JP (1) JP4800961B2 (pl)
AT (1) ATE361085T1 (pl)
DE (2) DE10352822A1 (pl)
ES (1) ES2285570T3 (pl)
PL (1) PL1687014T3 (pl)
WO (1) WO2005046705A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004038155A1 (de) * 2004-08-06 2006-03-16 Bioghurt Biogarde Gmbh & Co. Kg Physiologisch verträgliche Zusammensetzung enthaltend alpha-Liponsäure, Kreatin und ein Phospholipid
EP1991241A4 (en) * 2006-02-23 2009-07-08 Iomedix Sleep Internat Srl COMPOSITIONS AND METHODS FOR INTRODUCING AND MAINTAINING HIGH-QUALITY SLEEPING
CA2676518A1 (en) * 2008-08-29 2010-02-28 Kraft Foods Global Brands Llc Whey protein pre-load
WO2011015897A1 (en) * 2009-08-03 2011-02-10 Alexander Soldatov Probiotic food products comprising cereal grains crop and pasta as a starting material and methods for manufacturing the same
ITCN20120016A1 (it) * 2012-11-26 2014-05-27 Alessio Lilliu Processo produttivo atto alla creazione di prodotti alimentari ipocalorici e/o adatti a pazienti diabetici, derivanti da materie prime sottoposte a modificazione biochimica del substrato ad opera di lieviti e, successivamente, resi stabili e sicuri s

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712986A1 (de) * 1987-04-16 1988-10-27 Marbert Gmbh Medizinische zubereitungen auf der grundlage von biertreberextrakt, verfahren zu deren herstellung sowie verwendung von biertreberextrakt zur herstellung von kosmetischen zubereitungen und ein spezieller biertreberextrakt
DE3904962C2 (de) * 1989-02-18 1998-07-16 Else Toelle Verfahren zur Herstellung von Lebensmitteln, diätetischen Lebensmitteln und Lebensmitteln und Lebensmittelzusätzen auf Basis von Getreideschlempe
US5468727A (en) * 1990-12-13 1995-11-21 Board Of Regents, The University Of Texas System Methods of normalizing metabolic parameters in diabetics
JPH10146166A (ja) * 1996-11-18 1998-06-02 Nippon Shuzo Kumiai Chiyuuoukai 生理活性組成物
EP1199950B1 (de) * 1999-08-05 2005-10-26 Marc Tölle Verfahren zur herstellung von lebensmitteln, diätetischen lebensmitteln und lebensmittelzusätzen auf basis von getreideschlempe
JP2002371003A (ja) * 2001-06-15 2002-12-26 Kikkoman Corp 血糖値上昇抑制剤

Also Published As

Publication number Publication date
DE502004003726D1 (de) 2007-06-14
JP4800961B2 (ja) 2011-10-26
ES2285570T3 (es) 2007-11-16
EP1687014B1 (de) 2007-05-02
JP2007510694A (ja) 2007-04-26
ATE361085T1 (de) 2007-05-15
DE10352822A1 (de) 2005-06-23
EP1687014A1 (de) 2006-08-09
WO2005046705A1 (de) 2005-05-26
US20070141119A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
GB2441939A (en) Surgical membrane
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
IL181601A0 (en) Ferulate esterase producing strains and methods of using same
HUP0203256A2 (hu) Eljárás magas vérnyomás elleni tripeptideket tartalmazó készítmény előállítására
SG146682A1 (en) Modulation of eif4e expression
WO2006015035A8 (en) Useful compounds for hpv infection
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
PL1753440T3 (pl) Forma do podawania doustnego zawierająca bakterie probiotyczne
WO2007025977A3 (en) Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
WO2004024064A8 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
TW200506059A (en) Method for obtaining mastocyte lines from pig tissues and for producing heparin-type molecules
PL1687014T3 (pl) Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi
TW200745132A (en) Novel, acyclically substituted furopyrimidine derivatives and use thereof
PL374524A1 (pl) Kompozycja na bazie cytrynianu trójetylowego w leczeniu bakteryjnych zakażeń skóry
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
AU2003206926A1 (en) Cultivation method for micro-organisms and bioreactor
EP1610814B8 (en) Therapeutic composition for autoimmune conditions
WO2003062197A3 (en) Nek2 inhibitors
TW200708312A (en) Cosmetic composition used for cleaning skin
WO2003043565A3 (en) Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
AU2003286294A1 (en) Process to improve milk coagulation by means of strains of lactic bacteria, new strains and their use in said process
WO2004028447A3 (en) Novel compositions and methods for the treatment of psoriasis
MX2008001548A (es) Compuestos antitumorales.
WO2004071384A3 (en) New pharmaceutical compositions based on anticholinergics and tace-inhibitors